Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Kaplan Matthew L.
Director at Nuvectis Pharma. Filing since 12 May 2022.
CIK 0001895952
Company
Date
Role
Action
Shares
Amount
Of holding
NVCT
Nuvectis Pharma, Inc.
5 Nov 2025
Director
Bought
11,000
$64.24K
9.7%
NVCT
Nuvectis Pharma, Inc.
12 May 2022
Director
Bought
3,000
$50.63K
9.2%
2 decisions on file.
